Yujun Wu of Sanofi-Aventis will discuss "Approaches to Handling Data When a Phase II Trial Deviates from the Pre-specified Simon’s Two-Stage Design" at a Statistics Seminar on March 5 at 4 p.m. in Cullimore Hall Rm. 611.